Enhancing Endovascular Procedures for Improved Clinical Outcomes.
Arch Protection System
Clinical evidence is emerging that suggests an increased risk of stroke is associated with emerging therapies such as trans-aortic valve implantation (TAVI). Lumen believes its platform technology has the ability to offer novel solutions to potentially improve patient outcomes for this and similar procedures.
Ischemic Stroke System
Stroke is the third leading cause of death and the leading cause of disability in the United States. Lumen believes its platform technology can be applied to develop a novel device designed to revascularize or open up a blood vessel that is blocked by a blood clot.